COVID-19: Clinical Research

Return to Clinical Research

Read the following information from the Vice President for Research (VPR) regarding resuming clinical research.

 

Research ramp-up guidance:   https://research.virginia.edu/research-ramp-guidance

Human subject research specific guidance: https://research.virginia.edu/sites/vpr/files/2020-06/ReturnToClinicalResearchJune30.2020.pdf 

Collins Wing Clinical Research Unit

Operation status: Normal

Effective July 1, 2020: All clinical research studies can proceed on the Clinical Research Units only to the extent that it can be performed safely for research subjects and staff.

CRU Guidance for resuming operations_Collins

Fontaine Clinical Research Unit

Operation status: Normal

Effective July 1, 2020: All clinical research studies can proceed on the Clinical Research Units only to the extent that it can be performed safely for research subjects and staff.

CRU Guidance for resuming operations_Fontaine

Clinical Research Sponsor/Monitor Visits

Updated September 09, 2021– Effective immediately, all clinical research sponsors/monitors who come on site must be fully vaccinated.

Onsite sponsor/monitor visits are permitted in clinical and non-clinical areas and there is no limit on the number of representatives that can visit.

However, please note that Investigational Drug Services has specific requirements for on-site IDS monitoring:

  • Limit visit to 1 person
  • Site visits will be scheduled through normal methods.
  • IDS retains the option to restrict the number of visits scheduled in any one day to allow for appropriate distancing, etc.

Research Concierge at UVA Health Science Library

This service has been cancelled until further notice.

FAQ

There is a list of FAQs that you can reference to address your questions (https://research.virginia.edu/human-research-protection-program/COVID19FAQs).